Open AccessPrevalence of hyperhomocysteinemia, dyslipidemia and subclinical inflammatory syndrome in patients with repeated ischemic attack and stroke
Author(s) -
G. V. Bezsmertna
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.3.71.2014.124
Subject(s) - hyperhomocysteinemia , homocysteine , medicine , dyslipidemia , subclinical infection , metabolic syndrome , stroke (engine) , ischemic stroke , disease , gastroenterology , cardiology , ischemia , obesity , mechanical engineering , engineering
The prevalence of metabolic disorders in homocysteine, lipids and subclinical inflammatory syndrome were studied in 153 patients with primary and recurrent ischemic stroke. The severe course of cerebrovascular disease is associated with metabolic disorders, especially with hyperhomocysteinemia. In patients with recurrent ischemic attacks and strokes, as compared with the primary ones, high levels of homocysteine, lipids and inflammatory markers are more frequently diagnosed and the proportion of individuals with hyperhomocysteinemia, hypercholesterolemia and aberrant levels of interleukin -6 increases.